Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials.

By John R. Geddes, S. Burgess, K. Hawton, K. Jamison, Guy M. Goodwin. American Journal of Psychiatry, 2004

622 citations recorded by the source corpus.

Subfields: Organic Chemistry, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/cf1a27387fa84c77bd46c599f0bd5684f186da8c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. G. Malhi
2. R. Porter
3. R. Mulder
4. Paul B. Fitzgerald
5. G. Murray
6. Ajeet B Singh
7. Richard A. Bryant
8. M. Hopwood

Citations in the corpus

• Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (2015, background): “risk of relapse of a manic episode by 40% to 61%, with modestly lower efficacy in the prevention of depressive relapse (Geddes et al., 2004).”
• The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. (2019, neutral): “325 Mood stabilisers are the most effective treatment for bipolar affective disorder, 263 and drugs for depression (or antidepressants) have an important role in the treatment of depression.”